EUVIMEDEUVIMED entdecken
Crossref

AN EXPLAINABLE ENSEMBLE GENOMIC PIPELINE FOR CONSISTENT CANCER THERAPY DECISIONS

S. Vidhya, S. Prabakaran, V. Vijayakumar, Gobikha P S, P. Anbumani, Asmitha S

International Journal of Drug Delivery Technology · 01.07.2026 · 16 (60s)

DOI: 10.25258/ijddt.16.60s.155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.07.2026. Verfasst von S. Vidhya und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Precision oncology is focused on the personalization of cancer treatment with references to the molecular profile of the patients. Nonetheless, the inconsistency of the interpretation of genomics, feature selection, and data preprocessing can usually result in varied treatment advice, restricting clinical repeatability and trust in AI-supported judgment.

Objective

To solve these issues, in this work, we will present an Explainable Ensemble Genomic Pipeline (XEGP) to help offer standardized and reproducible therapy advice. Materials and Methods The pipeline combines both powerful preprocessing of genomic data, high-resolution biomarker extraction, and sophisticated feature selection methods to minimize noise and inter-sample variability. An ensemble decision engine is a system that combines the forecasts of various machine learning models and enhances performance and reduces uncertainty during therapy recommendations. The explainable AI modules (feature attribution and decision visualization) in XEGP can be used to improve clinical interpretability by allowing an oncologist to learn how important mutations and expressions influence therapy choices.

Results

The findings of experimental testing on several benchmark cancer genomic datasets indicate a higher degree of consistency of the decision-making, predictive accuracy, and reproducibility as compared to the traditional methods.

Conclusion

The suggested framework can be applied to various cancer types and groups of patients, and it will provide a clinically understandable and user-friendly AI-assisted tool. XEGP allows the realization of the gap between high-throughput genomic analysis and reproducible and reliable precision oncology choices: they are all in the same framework to unify the preprocessing, ensemble modeling, and explainability process.

Zitieren

APA

Vidhya, S., Prabakaran, S., Vijayakumar, V., S, G. P., Anbumani, P., & S, A. (2026). AN EXPLAINABLE ENSEMBLE GENOMIC PIPELINE FOR CONSISTENT CANCER THERAPY DECISIONS. International Journal of Drug Delivery Technology, 16(60s). https://doi.org/10.25258/ijddt.16.60s.155

Vancouver

Vidhya S, Prabakaran S, Vijayakumar V, S GP, Anbumani P, S A. AN EXPLAINABLE ENSEMBLE GENOMIC PIPELINE FOR CONSISTENT CANCER THERAPY DECISIONS. International Journal of Drug Delivery Technology. 2026;16(60s). doi:10.25258/ijddt.16.60s.155

BibTeX
@article{Vidhya2026,
  author = {Vidhya, S. and Prabakaran, S. and Vijayakumar, V. and S, Gobikha P and Anbumani, P. and S, Asmitha},
  title = {AN EXPLAINABLE ENSEMBLE GENOMIC PIPELINE FOR CONSISTENT CANCER THERAPY DECISIONS},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {60s},
  doi = {10.25258/ijddt.16.60s.155}
}
Kostenlos starten →